Stephen Bardin - 16 Aug 2022 Form 3 Insider Report for ATAI Life Sciences N.V. (ATAI)

Role
Chief Financial Officer
Signature
/s/ Ryan Barrett, Attorney-in-fact
Issuer symbol
ATAI
Transactions as of
16 Aug 2022
Net transactions value
$0
Form type
3
Filing time
17 Aug 2022, 06:05:11 UTC
Next filing
16 Mar 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding ATAI Stock Option 16 Aug 2022 Ordinary Shares 1,000,000 $3.65 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests as to 25% of the underlying shares on June 27, 2023, and in 36 substantially equal monthly installments thereafter.

Remarks:

Exhibit 24 - Power of Attorney.